Cargando…
Single variable domains from the T cell receptor β chain function as mono- and bifunctional CARs and TCRs
Cell therapy using T cell receptors (TCRs) and chimeric antigen receptors (CARs) represents a new wave of immunotherapies garnering considerable attention and investment. Further progress in this area of medicine depends in part on improving the functional capabilities of the engineered components,...
Autores principales: | Oh, Julyun, Warshaviak, Dora Toledo, Mkrtichyan, Mikayel, Munguia, Melanie Lisette, Lin, Abby, Chai, Falene, Pigott, Craig, Kang, Jaspal, Gallo, Michael, Kamb, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872726/ https://www.ncbi.nlm.nih.gov/pubmed/31754147 http://dx.doi.org/10.1038/s41598-019-53756-4 |
Ejemplares similares
-
Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers
por: Wang, Xueyin, et al.
Publicado: (2021) -
Turn to TCRs when CARs fail
por: Stauss, Hans J.
Publicado: (2017) -
Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs
por: Anikeeva, Nadia, et al.
Publicado: (2021) -
TCRs alive on the periphery
por: Tuma, Rabiya S.
Publicado: (2005) -
Adoptive Immunotherapy Based on Chain-Centric TCRs in Treatment of Infectious Diseases
por: Kalinina, Anastasiia A., et al.
Publicado: (2020)